SI9111731B - Novel 3-cycloalkyl-propanamides, their tautomeric forms, their salts, processes for their preparation, use as medicaments and preparations containing them - Google Patents

Novel 3-cycloalkyl-propanamides, their tautomeric forms, their salts, processes for their preparation, use as medicaments and preparations containing them Download PDF

Info

Publication number
SI9111731B
SI9111731B SI9111731A SI9111731A SI9111731B SI 9111731 B SI9111731 B SI 9111731B SI 9111731 A SI9111731 A SI 9111731A SI 9111731 A SI9111731 A SI 9111731A SI 9111731 B SI9111731 B SI 9111731B
Authority
SI
Slovenia
Prior art keywords
formula
radical
cycloalkyl
hal
product
Prior art date
Application number
SI9111731A
Other languages
English (en)
Slovenian (sl)
Other versions
SI9111731A (en
Inventor
Philip Thomas Hambleton
Charles John Robert Hedgecock
David Paul Kay
Elizabeth Anne Kuo
Wilfred Roger Tully
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909023535A external-priority patent/GB9023535D0/en
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of SI9111731A publication Critical patent/SI9111731A/sl
Publication of SI9111731B publication Critical patent/SI9111731B/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/24—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton
    • C07C255/27—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton containing cyano groups, amino groups and doubly-bound oxygen atoms bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/31—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C07C255/60—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton at least one of the singly-bound nitrogen atoms being acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/40—Y being a hydrogen or a carbon atom
    • C07C323/41—Y being a hydrogen or an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
SI9111731A 1990-10-30 1991-10-30 Novel 3-cycloalkyl-propanamides, their tautomeric forms, their salts, processes for their preparation, use as medicaments and preparations containing them SI9111731B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB909023535A GB9023535D0 (en) 1990-10-30 1990-10-30 Chemical compounds
GB919105516A GB9105516D0 (en) 1990-10-30 1991-03-15 Chemical compounds
YU173191A YU48688B (sh) 1990-10-30 1991-10-30 Novi 3-cikloalkil-propanamidi, njihovi tautomerni oblici, njihove soli, postupak za dobivanje

Publications (2)

Publication Number Publication Date
SI9111731A SI9111731A (en) 1997-12-31
SI9111731B true SI9111731B (en) 2001-02-28

Family

ID=26297867

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9111731A SI9111731B (en) 1990-10-30 1991-10-30 Novel 3-cycloalkyl-propanamides, their tautomeric forms, their salts, processes for their preparation, use as medicaments and preparations containing them

Country Status (25)

Country Link
US (2) US5240960B1 (hu)
EP (1) EP0484223B1 (hu)
JP (1) JP2594855B2 (hu)
CN (1) CN1030075C (hu)
AT (1) ATE119518T1 (hu)
AU (1) AU641290B2 (hu)
BG (1) BG61924B2 (hu)
BR (1) BR9104711A (hu)
CA (1) CA2054473C (hu)
CZ (1) CZ282036B6 (hu)
DE (1) DE69107959T2 (hu)
DK (1) DK0484223T3 (hu)
ES (1) ES2069854T3 (hu)
FI (2) FI110511B (hu)
GE (1) GEP19981035B (hu)
GR (1) GR3015335T3 (hu)
HR (1) HRP920979B1 (hu)
HU (2) HU215051B (hu)
IE (1) IE69330B1 (hu)
IL (1) IL99811A (hu)
NO (1) NO175898C (hu)
NZ (1) NZ240403A (hu)
PT (1) PT99381B (hu)
SI (1) SI9111731B (hu)
SK (1) SK281720B6 (hu)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99811A (en) * 1990-10-30 1996-03-31 Roussel Uclaf 3-Cycloalkyl-propanamides, tautomeric forms of these, their salts, method of preparation, use as drugs and preparations containing them
IL102790A (en) * 1991-09-17 1996-01-31 Roussel Uclaf History of 3-cycloalkyl-prop-2-anamide
ES2079765T3 (es) * 1991-10-23 1996-01-16 Hoechst Ag Derivados de amidas de acido n-fenil-2-ciano-3-hidroxicrotonico y su utilizacion como medicamento con propiedad inmunomoduladora.
GB9200275D0 (en) * 1992-01-08 1992-02-26 Roussel Lab Ltd Chemical compounds
GB9300083D0 (en) * 1993-01-05 1993-03-03 Roussel Lab Ltd Chemical compounds
TW314467B (hu) * 1993-03-31 1997-09-01 Hoechst Ag
GB9313365D0 (en) * 1993-06-29 1993-08-11 Roussel Lab Ltd Chemical compounds
US5519042A (en) * 1994-01-13 1996-05-21 Hoechst Aktiengesellschaft Method of treating hyperproliferative vascular disease
FR2727628B1 (fr) * 1994-12-02 1997-01-10 Roussel Uclaf Application des derives de 3-cycloalkyl-propanamide a titre de medicaments analgesiques
GB9520092D0 (en) * 1995-10-02 1995-12-06 Hoechst Roussel Ltd Chemical compounds
DE19539638A1 (de) * 1995-10-25 1997-04-30 Hoechst Ag Die Verwendung von Isoxazol- und Crotonsäureamidderivaten zur Behandlung von Krebserkrankungen
DE19547648A1 (de) 1995-12-20 1997-06-26 Hoechst Ag Zubereitung, enthaltend High Density Lipoproteine und Crotonsäureamidderivate
US5856330A (en) * 1996-07-31 1999-01-05 Hoechst Aktiengesellschaft Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin
US5981536A (en) * 1996-07-31 1999-11-09 Hoechst Aktiengesellschaft Use of xanthine derivatives for the modulation of apoptosis
US6011051A (en) * 1996-07-31 2000-01-04 Hoechst Aktiengesellschaft Use of isoxazole and crotonamide derivatives for the modulation of apoptosis
US6355678B1 (en) 1998-06-29 2002-03-12 Parker Hughes Institute Inhibitors of the EGF-receptor tyrosine kinase and methods for their use
AU731777B2 (en) 1998-11-30 2001-04-05 Nihon Nohyaku Co., Ltd. Aniline derivative and process for producing the same
US6566395B1 (en) 1999-05-25 2003-05-20 Biomedicines, Inc. Methods of treating proliferative disorders
JP2016537360A (ja) 2013-11-22 2016-12-01 ジェンザイム・コーポレーション 神経変性疾患を治療するための新規な方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR831461A (fr) * 1937-01-09 1938-09-05 Ste Ind Chim Bale Nouveaux produits de condensation
US3116312A (en) * 1960-03-31 1963-12-31 American Cyanamid Co Substituted-2-cyanoacetanilides
NL6911567A (hu) * 1968-08-08 1970-02-10
DE2307156A1 (de) * 1973-02-14 1974-08-22 Henkel & Cie Gmbh N,n-disubstituierte alpha-cyanacrylsaeureamide und deren herstellung
DE2555789A1 (de) * 1975-12-11 1977-07-07 Hoechst Ag Neue cyanessigsaeureanilid-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel
US4393217A (en) * 1981-01-12 1983-07-12 American Cyanamid Company Substituted phenyl-5-aminopyrazoles
US4946867A (en) * 1987-09-07 1990-08-07 Sumitomo Chemical Company, Limited Cyanoacetamide derivative, and plant disease protectant comprising the same as an active ingredient
US4888357A (en) * 1988-01-26 1989-12-19 Bristol-Myers Company Antiarthritic β-cycloalkyl-β-oxopropionitriles
US5034410A (en) * 1989-10-11 1991-07-23 Syntex (U.S.A.) Inc. Anthelmintically active benzenepropanamide derivatives
IL99811A (en) * 1990-10-30 1996-03-31 Roussel Uclaf 3-Cycloalkyl-propanamides, tautomeric forms of these, their salts, method of preparation, use as drugs and preparations containing them

Also Published As

Publication number Publication date
IL99811A (en) 1996-03-31
HRP920979B1 (en) 2000-06-30
JP2594855B2 (ja) 1997-03-26
IL99811A0 (en) 1992-08-18
HU913394D0 (en) 1992-01-28
FI119986B (fi) 2009-05-29
CS327391A3 (en) 1992-05-13
DK0484223T3 (da) 1995-06-19
US5384423A (en) 1995-01-24
NO175898B (no) 1994-09-19
ES2069854T3 (es) 1995-05-16
NO914232L (no) 1992-05-04
CA2054473A1 (fr) 1992-05-01
PT99381B (pt) 1999-04-30
IE69330B1 (en) 1996-09-04
GR3015335T3 (en) 1995-06-30
SK281720B6 (sk) 2001-07-10
NZ240403A (en) 1994-10-26
NO175898C (no) 1994-12-28
EP0484223A3 (en) 1993-04-07
FI110511B (fi) 2003-02-14
AU8686991A (en) 1992-05-07
SI9111731A (en) 1997-12-31
CN1064482A (zh) 1992-09-16
FI20021681A (fi) 2002-09-20
HRP920979A2 (en) 1997-12-31
PT99381A (pt) 1992-09-30
HU211614A9 (en) 1995-12-28
AU641290B2 (en) 1993-09-16
CN1030075C (zh) 1995-10-18
DE69107959T2 (de) 1995-11-16
ATE119518T1 (de) 1995-03-15
CZ282036B6 (cs) 1997-04-16
HUT59661A (en) 1992-06-29
FI915091A0 (fi) 1991-10-29
IE913768A1 (en) 1992-05-22
US5240960B1 (en) 1995-05-02
FI915091A (fi) 1992-05-01
BG61924B2 (bg) 1998-09-30
EP0484223A2 (fr) 1992-05-06
CA2054473C (fr) 2003-07-29
HU215051B (hu) 1998-12-28
JPH04288048A (ja) 1992-10-13
GEP19981035B (en) 1998-03-26
NO914232D0 (no) 1991-10-29
BR9104711A (pt) 1992-06-16
US5240960A (en) 1993-08-31
DE69107959D1 (de) 1995-04-13
EP0484223B1 (fr) 1995-03-08

Similar Documents

Publication Publication Date Title
SI9111731B (en) Novel 3-cycloalkyl-propanamides, their tautomeric forms, their salts, processes for their preparation, use as medicaments and preparations containing them
JPH02117664A (ja) ４‐ピリドン‐３‐カルボン酸およびその誘導体
RU2009110413A (ru) Способ получения производных 3-дигалогенметил-пиразол-4-карбоновой кислоты
CZ285586B6 (cs) Chemické sloučeniny
MX2014009922A (es) Metodos para producir compuestos sulfilimina.
EP0124476A1 (de) Carboxamide, Verfahren zur Herstellung und pharmazeutische Präparate, die diese enthalten
EP0135975B1 (en) Quinazoline and isoquinoline derivatives
DE2359536A1 (de) 2,6-diaminonebularinderivate
DE10085384B4 (de) Ein Verfahren für die Herstellung von 6-(2,3-Dichlorphenyl)-1,2,4-triazin -3,5-diamin, im Allgemeinen bekannt als Lamotrigin
DE69824839T2 (de) Verfahren zur herstellung von 2-aryl-3-aryl-5-halogen-pyridinen, verwendbar als cox-2 inhibitoren
CH647237A5 (de) 5-thiobenzimidazol-derivate, verfahren zur herstellung derselben und deren verwendung in anthelmintischen praeparaten.
DE2147488A1 (de) Adenosinderivate und Verfahren zu ihrer Herstellung
ES2519441T3 (es) Compuestos para tratar la impotencia
SK280095B6 (sk) Substituovaný beta-diketón, spôsob jeho prípravy a
BRPI0611038B1 (pt) Processo para preparar 4-(1,6-diidro-6-oxo-2-pirimidinil)amino benzonitrila e composto intermediário
US4537781A (en) Pharmaceutically useful malonamides
IE47930B1 (en) Benzylidene derivatives
BRPI0417179A (pt) gentisato de amlodipina, método de preparar o mesmo e composição farmacêutica para tratamento de doenças cardiovasculares
US3651134A (en) 5-arylalkoxy-1-hydroxy-2-naphthoic acids
DK144822B (da) Analogifremgangsmaade til fremstilling af hoejredrejende 7-brom-6-chlor-3-(3-(3-hydroxy-2-peperidyl)-acetonyl)-4-3h-quinazolinon eller dets additionssalte med syrer
DE3111025A1 (de) "aminosaeurederivate, deren herstellung und deren verwendung als arzneimittel"
DK143847B (da) Analogifremgangsmaade til fremstilling af imidazolderivater
DE2847825A1 (de) 2,4-diamino-5-benzylpyrimidine und verfahren zu deren herstellung
Urbanski et al. Potential Antimalarial Compounds. 1 IX. 2 Pyrimidine Derivatives of Urea and Guanidine
Dryanska Phase-Transfer Catalyzed Additions. IV1. Addition of tert-Butyl Phenylacetate to Activated Double Bond

Legal Events

Date Code Title Description
IF Valid on the event date